Evidence map›Paper›PMID 37916396›Full record

ArticleHaematologica2024

SH2 domain-containing inositol 5-phosphatases support the survival of Burkitt lymphoma cells by promoting energy metabolism.

Florian Mayr, Vanessa Kruse, Dominik C Fuhrmann, Sebastian Wolf, Jens Löber, Saed Alsouri, Nadia Paglilla, Kwang Lee, Björn Chapuy, Bernhard Brüne and 4 more

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Florian MayrInstitute for Cellular and Molecular Immunology, University Medical Center Göttingen.
Vanessa KruseInstitute for Cellular and Molecular Immunology, University Medical Center Göttingen.
Dominik C FuhrmannInstitute for Biochemistry I, Faculty of Medicine, Johann Wolfgang Goethe-University Frankfurt.
Sebastian WolfDepartment of Hematology/Oncology, Johann Wolfgang Goethe University, Frankfurt.
Jens LöberDepartment of Hematology, Oncology and Cancer Immunology, Charité, Campus Benjamin Franklin.
Saed AlsouriInstitute for Cellular and Molecular Immunology, University Medical Center Göttingen.
Nadia PaglillaInstitute for Cellular and Molecular Immunology, University Medical Center Göttingen.
Kwang LeeTranslational Medical Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg.
Björn ChapuyDepartment of Hematology, Oncology and Cancer Immunology, Charité, Campus Benjamin Franklin.
Bernhard BrüneInstitute for Biochemistry I, Faculty of Medicine, Johann Wolfgang Goethe-University Frankfurt.
Thorsten ZenzDepartment of Medical Oncology and Hematology, University Hospital Zurich.
Björn HäuplDepartment of Hematology/Oncology, Johann Wolfgang Goethe University, Frankfurt, Germany; German Cancer Consortium (DKTK), Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Frankfurt Cancer Institute, Johann Wolfgang Goethe University Frankfurt, Frankfurt.
Thomas OellerichDepartment of Hematology/Oncology, Johann Wolfgang Goethe University, Frankfurt, Germany; German Cancer Consortium (DKTK), Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Frankfurt Cancer Institute, Johann Wolfgang Goethe University Frankfurt, Frankfurt.
Michael EngelkeInstitute for Cellular and Molecular Immunology, University Medical Center Göttingen. michael.engelke@med.uni-goettingen.de.
Universitätsmedizin Göttingen · DEGoethe University Frankfurt · DECharité - Universitätsmedizin Berlin · DEHeidelberg University · DENational Center for Tumor Diseases · DEUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Burkitt lymphoma cells (BL) exploit antigen-independent tonic signals transduced by the B-cell antigen receptor (BCR) for their survival, but the molecular details of the rewired BL-specific BCR signal network remain unclear. A loss of function screen revealed the SH2 domain-containing 5`-inositol phosphatase 2 (SHIP2) as a potential modulator of BL fitness. We characterized the role of SHIP2 in BL survival in several BL cell models and show that perturbing SHIP2 function renders cells more susceptible to apoptosis, while attenuating proliferation in a BCR-dependent manner. Unexpectedly, SHIP2 deficiency did neither affect PI3K survival signals nor MAPK activity, but attenuated ATP production. We found that an efficient energy metabolism in BL cells requires phosphatidylinositol-3,4-bisphosphate (PI(3,4)P2), which is the enzymatic product of SHIP proteins. Consistently, interference with the function of SHIP1 and SHIP2 augments BL cell susceptibility to PI3K inhibition. Notably, we provide here a molecular basis of how tonic BCR signals are connected to energy supply, which is particularly important for such an aggressively growing neoplasia. These findings may help to improve therapies for the treatment of BL by limiting energy metabolism through the inhibition of SHIP proteins, which renders BL cells more susceptible to the targeting of survival signals.

Indexed as

Burkitt LymphomaCell SurvivalEnergy MetabolismPhosphatidylinositol-3,4,5-Trisphosphate 5-PhosphatasesApoptosisCell Line, TumorCell ProliferationHumansReceptors, Antigen, B-CellSignal Transductionsrc Homology DomainsINPP5D protein, humanPhosphatidylinositol-3,4,5-Trisphosphate 5-PhosphatasesReceptors, Antigen, B-Cell

Identifiers

PMID37916396
PMCPMC11063853
OpenAlexW4388226571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.